Sheri TrutwinHead of Strategic Accounts at Alnylam PharmaceuticalsSpeaker
Profile
Sheri Trutwin is a leader in the design and execution of cross-functional, enterprise-enabling teams and strategies that improve patient experience, outcomes and access for life science organizations. Sheri launched the Strategic Account Management (SAM) capability at Alnylam, a rapidly growing, commercial-stage biopharmaceutical company that was the first to discover and develop a new class of medicines based on RNA interference (RNAi). Sheri oversees organization-wide co-development of solutions that meet gaps in care within organized customers, such as Integrated Delivery Networks. She has spent more than two decades at commercial medical device and life science companies such as Shire and most recently Acadia, where she was US Head of Health Systems, a division she created.
Agenda Sessions
Manufacturer and Integrated Delivery Network Collaboration
, 9:30amView Session